{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T19:54:56Z","timestamp":1791230096525,"version":"4.1.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,2]],"date-time":"2025-01-02T00:00:00Z","timestamp":1735776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,1,2]],"date-time":"2025-01-02T00:00:00Z","timestamp":1735776000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-024-84021-y","type":"journal-article","created":{"date-parts":[[2025,1,2]],"date-time":"2025-01-02T21:51:30Z","timestamp":1735854690000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Peroxiredoxin 6 maintains mitochondrial homeostasis and promotes tumor progression through ROS\/JNK\/p38 MAPK signaling pathway in multiple myeloma"],"prefix":"10.1038","volume":"15","author":[{"given":"Dandan","family":"Gao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gongzhizi","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zujie","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruoyu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinsong","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aili","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pengyu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,2]]},"reference":[{"issue":"2","key":"84021_CR1","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1038\/leu.2017.329","volume":"32","author":"CS Chim","year":"2017","unstructured":"Chim, C. S. et al. Management of relapsed and refractory multiple myeloma: novel agents, antibodies, immunotherapies and beyond. Leukemia 32(2), 252\u2013262. https:\/\/doi.org\/10.1038\/leu.2017.329 (2017).","journal-title":"Leukemia"},{"issue":"4","key":"84021_CR2","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1007\/s10555-017-9707-8","volume":"36","author":"S Gandolfi","year":"2017","unstructured":"Gandolfi, S. et al. The proteasome and proteasome inhibitors in multiple myeloma. Cancer Metastasis Rev. 36(4), 561\u2013584. https:\/\/doi.org\/10.1007\/s10555-017-9707-8 (2017).","journal-title":"Cancer Metastasis Rev."},{"key":"84021_CR3","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.ctrv.2018.09.001","volume":"70","author":"P Robak","year":"2018","unstructured":"Robak, P., Drozdz, I., Szemraj, J. & Robak, T. Drug resistance in multiple myeloma. Cancer Treat. Rev. 70, 199\u2013208. https:\/\/doi.org\/10.1016\/j.ctrv.2018.09.001 (2018).","journal-title":"Cancer Treat. Rev."},{"issue":"7","key":"84021_CR4","doi-asserted-by":"publisher","first-page":"4403","DOI":"10.1074\/jbc.r111.283432","volume":"287","author":"SG Rhee","year":"2012","unstructured":"Rhee, S. G., Woo, H. A., Kil, I. S. & Bae, S. H. Peroxiredoxin functions as a peroxidase and a regulator and sensor of local peroxides. J. Biol. Chem. 287(7), 4403\u20134410. https:\/\/doi.org\/10.1074\/jbc.r111.283432 (2012).","journal-title":"J. Biol. Chem."},{"issue":"12","key":"84021_CR5","doi-asserted-by":"publisher","first-page":"172","DOI":"10.3390\/antiox7120172","volume":"7","author":"J Arevalo","year":"2018","unstructured":"Arevalo, J. & V\u00e1zquez-Medina, J. The role of peroxiredoxin 6 in cell signaling. Antioxidants 7(12), 172. https:\/\/doi.org\/10.3390\/antiox7120172 (2018).","journal-title":"Antioxidants"},{"issue":"2","key":"84021_CR6","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.biocel.2012.11.005","volume":"45","author":"S Zhou","year":"2013","unstructured":"Zhou, S. et al. Functional interaction of glutathione S-transferase pi and peroxiredoxin 6 in intact cells. Int. J. Biochem. Cell Biol. 45(2), 401\u2013407. https:\/\/doi.org\/10.1016\/j.biocel.2012.11.005 (2013).","journal-title":"Int. J. Biochem. Cell Biol."},{"issue":"4","key":"84021_CR7","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1194\/jlr.m064758","volume":"57","author":"AB Fisher","year":"2016","unstructured":"Fisher, A. B. et al. A novel lysophosphatidylcholine acyl transferase activity is expressed by peroxiredoxin 6. J. Lipid Res. 57(4), 587\u2013596. https:\/\/doi.org\/10.1194\/jlr.m064758 (2016).","journal-title":"J. Lipid Res."},{"key":"84021_CR8","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.freeradbiomed.2014.02.001","volume":"69","author":"H-M Yun","year":"2014","unstructured":"Yun, H-M. et al. PRDX6 promotes lung tumor progression via its GPx and iPLA2 activities. Free Radic. Biol. Med. 69, 367\u2013376. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2014.02.001 (2014).","journal-title":"Free Radic. Biol. Med."},{"issue":"3","key":"84021_CR9","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1111\/j.1601-0825.2010.01730.x","volume":"17","author":"C-F Huang","year":"2010","unstructured":"Huang, C-F. et al. Increased expression of peroxiredoxin 6 and cyclophilin A in squamous cell carcinoma of the tongue. Oral Dis. 17(3), 328\u2013334. https:\/\/doi.org\/10.1111\/j.1601-0825.2010.01730.x (2010).","journal-title":"Oral Dis."},{"issue":"1","key":"84021_CR10","doi-asserted-by":"publisher","first-page":"21","DOI":"10.3109\/07357907.2010.535056","volume":"29","author":"JH Pak","year":"2010","unstructured":"Pak, J. H. et al. Peroxiredoxin 6 overexpression attenuates Cisplatin-Induced apoptosis in human ovarian Cancer cells. Cancer Invest. 29(1), 21\u201328. https:\/\/doi.org\/10.3109\/07357907.2010.535056 (2010).","journal-title":"Cancer Invest."},{"issue":"2","key":"84021_CR11","doi-asserted-by":"publisher","first-page":"207","DOI":"10.3233\/cbm-190708","volume":"27","author":"C Pagaza-Straffon","year":"2020","unstructured":"Pagaza-Straffon, C. et al. Evaluation of a panel of tumor-associated antigens in breast cancer. Cancer Biomarkers. 27(2), 207\u2013211. https:\/\/doi.org\/10.3233\/cbm-190708 (2020).","journal-title":"Cancer Biomarkers"},{"key":"84021_CR12","doi-asserted-by":"publisher","first-page":"10477","DOI":"10.2147\/ott.s211125","volume":"12","author":"J Xu","year":"2019","unstructured":"Xu, J. et al. Differential expression and effects of peroxiredoxin-6 on drug resistance and cancer stem cell-like properties in non-small cell lung cancer. OncoTargets Ther. 12, 10477\u201310486. https:\/\/doi.org\/10.2147\/ott.s211125 (2019).","journal-title":"OncoTargets Therapy"},{"key":"84021_CR13","doi-asserted-by":"publisher","unstructured":"Sahu, N. et al. Functional screening implicates mir-371-3p and peroxiredoxin 6 in reversible tolerance to cancer drugs. Nat. Commun. 7(1). https:\/\/doi.org\/10.1038\/ncomms12351 (2016).","DOI":"10.1038\/ncomms12351"},{"issue":"10","key":"84021_CR14","doi-asserted-by":"publisher","first-page":"2411","DOI":"10.3390\/cancers13102411","volume":"13","author":"M Caillot","year":"2021","unstructured":"Caillot, M., Dakik, H., Mazurier, F. & Sola, B. Targeting reactive oxygen species metabolism to induce myeloma cell death. Cancers (Basel) 13(10), 2411. https:\/\/doi.org\/10.3390\/cancers13102411 (2021).","journal-title":"Cancers (Basel)"},{"key":"84021_CR15","doi-asserted-by":"publisher","first-page":"114871","DOI":"10.1016\/j.jep.2021.114871","volume":"286","author":"F Panahzadeh","year":"2022","unstructured":"Panahzadeh, F., Mirnasuri, R. & Rahmati, M. Exercise and Syzygium aromaticum reverse memory deficits, apoptosis and mitochondrial dysfunction of the hippocampus in Alzheimer\u2019s disease. J. Ethnopharmacol. 286, 114871. https:\/\/doi.org\/10.1016\/j.jep.2021.114871 (2022).","journal-title":"J. Ethnopharmacol."},{"key":"84021_CR16","doi-asserted-by":"publisher","DOI":"10.1007\/s11011-022-00931-8","author":"A Mohammadipour","year":"2022","unstructured":"Mohammadipour, A. A focus on natural products for preventing and cure of mitochondrial dysfunction in Parkinson\u2019s disease. Metab. Brain Dis. https:\/\/doi.org\/10.1007\/s11011-022-00931-8 (2022).","journal-title":"Metabolic Brain Disease Published Online"},{"key":"84021_CR17","doi-asserted-by":"crossref","unstructured":"Quan, Y. Connexin gap junctions and hemichannels in modulating lens redox homeostasis and oxidative stress in cataractogenesis. Antioxidants (Basel) 10(9), 1374 (2021).","DOI":"10.3390\/antiox10091374"},{"issue":"12","key":"84021_CR18","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.1016\/j.freeradbiomed.2005.02.026","volume":"38","author":"SG Rhee","year":"2005","unstructured":"Rhee, S. G., Chae, H. Z. & Kim, K. Peroxiredoxins. A historical overview and speculative preview of novel mechanisms and emerging concepts in cell signaling. Free Radic. Biol. Med. 38(12), 1543\u20131552. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2005.02.026 (2005).","journal-title":"Free Radic. Biol. Med."},{"issue":"3","key":"84021_CR19","doi-asserted-by":"publisher","first-page":"52","DOI":"10.3390\/antiox8030052","volume":"8","author":"R Bannitz-Fernandes","year":"2019","unstructured":"Bannitz-Fernandes, R. et al. Non-mammalian Prdx6 enzymes (proteins with 1-Cys prdx mechanism) Display PLA2 activity similar to the human orthologue. Antioxidants 8(3), 52. https:\/\/doi.org\/10.3390\/antiox8030052 (2019).","journal-title":"Antioxidants"},{"key":"84021_CR20","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.brainres.2008.07.076","volume":"1233","author":"N Fatma","year":"2008","unstructured":"Fatma, N. et al. Peroxiredoxin 6 delivery attenuates TNF-\u03b1-and glutamate-induced retinal ganglion cell death by limiting ROS levels and maintaining Ca2\u2009+\u2009homeostasis. Brain Res. 1233, 63\u201378. https:\/\/doi.org\/10.1016\/j.brainres.2008.07.076 (2008).","journal-title":"Brain Res."},{"key":"84021_CR21","doi-asserted-by":"publisher","DOI":"10.1159\/000495934","author":"W-S Huang","year":"2018","unstructured":"Huang, W-S. Expression of PRDX6 correlates with migration and invasiveness of colorectal cancer cells. Cell. Physiol. Biochem. Published Online. https:\/\/doi.org\/10.1159\/000495934 (2018).","journal-title":"Cell. Physiol. Biochem. Published Online"},{"issue":"21","key":"84021_CR22","doi-asserted-by":"publisher","first-page":"3939","DOI":"10.7150\/jca.26041","volume":"9","author":"Y He","year":"2018","unstructured":"He, Y. et al. Overexpression of peroxiredoxin 6 (PRDX6) promotes the aggressive phenotypes of esophageal squamous cell carcinoma. J. Cancer. 9(21), 3939\u20133949. https:\/\/doi.org\/10.7150\/jca.26041 (2018).","journal-title":"J. Cancer"},{"issue":"5","key":"84021_CR23","doi-asserted-by":"publisher","first-page":"1772","DOI":"10.21037\/tcr.2019.08.36","volume":"8","author":"Z Fang","year":"2019","unstructured":"Fang, Z. et al. PRDX6 promotes proliferation and induces chemo-resistance via peroxidase activity in Toledo diffuse large B-cell lymphoma cells. Transl Cancer Res. 8(5), 1772\u20131781. https:\/\/doi.org\/10.21037\/tcr.2019.08.36 (2019).","journal-title":"Transl Cancer Res."},{"issue":"2","key":"84021_CR24","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.abb.2009.02.008","volume":"485","author":"Y Manevich","year":"2009","unstructured":"Manevich, Y. et al. Binding of peroxiredoxin 6 to substrate determines differential phospholipid hydroperoxide peroxidase and phospholipase A2 activities. Arch. Biochem. Biophys. 485(2), 139\u2013149. https:\/\/doi.org\/10.1016\/j.abb.2009.02.008 (2009).","journal-title":"Arch. Biochem. Biophys."},{"key":"84021_CR25","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.freeradbiomed.2014.12.022","volume":"80","author":"H-M Yun","year":"2015","unstructured":"Yun, H-M. et al. PRDX6 promotes tumor development via the JAK2\/STAT3 pathway in a urethane-induced lung tumor model. Free Radic. Biol. Med. 80, 136\u2013144. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2014.12.022 (2015).","journal-title":"Free Radic. Biol. Med."},{"issue":"6","key":"84021_CR26","doi-asserted-by":"publisher","first-page":"2217","DOI":"10.1159\/000430186","volume":"36","author":"X Zha","year":"2015","unstructured":"Zha, X. et al. PRDX6 protects ARPE-19 cells from oxidative damage via PI3K\/AKT signaling. Cell. Physiol. Biochem. 36(6), 2217\u20132228. https:\/\/doi.org\/10.1159\/000430186 (2015).","journal-title":"Cell. Physiol. Biochem."},{"key":"84021_CR27","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.ceb.2014.09.010","volume":"33","author":"CR Reczek","year":"2015","unstructured":"Reczek, C. R. & Chandel, N. S. ROS-dependent signal transduction. Curr. Opin. Cell Biol. 33, 8\u201313. https:\/\/doi.org\/10.1016\/j.ceb.2014.09.010 (2015).","journal-title":"Curr. Opin. Cell Biol."},{"issue":"6","key":"84021_CR28","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1038\/nrm3801","volume":"15","author":"KM Holmstr\u00f6m","year":"2014","unstructured":"Holmstr\u00f6m, K. M. & Finkel, T. Cellular mechanisms and physiological consequences of redox-dependent signalling. Nat. Rev. Mol. Cell Biol. 15(6), 411\u2013421. https:\/\/doi.org\/10.1038\/nrm3801 (2014).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"84021_CR29","doi-asserted-by":"crossref","unstructured":"Sorokina. E. M. et al. Intracellular targeting of peroxiredoxin 6 to lysosomal organelles requires MAPK activity and binding to 14-3-3\u03b5. Am. J. Physiol. Cell. Physiol. 300(6), C1430\u2013C1441 (2011).","DOI":"10.1152\/ajpcell.00285.2010"},{"issue":"6","key":"84021_CR30","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1016\/j.ajhg.2012.10.011","volume":"91","author":"L Basel-Vanagaite","year":"2012","unstructured":"Basel-Vanagaite, L. et al. Deficiency for the ubiquitin ligase UBE3B in a blepharophimosis-ptosis-intellectual-disability syndrome. Am. J. Hum. Genet. 91(6), 998\u20131010. https:\/\/doi.org\/10.1016\/j.ajhg.2012.10.011 (2012).","journal-title":"Am. J. Hum. Genet."},{"issue":"10","key":"84021_CR31","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1093\/neuonc\/nou088","volume":"16","author":"TH Kim","year":"2014","unstructured":"Kim, T. H. et al. Piperlongumine treatment inactivates peroxiredoxin 4, exacerbates endoplasmic reticulum stress, and preferentially kills high-grade glioma cells. Neuro-Oncology 16(10), 1354\u20131364. https:\/\/doi.org\/10.1093\/neuonc\/nou088 (2014).","journal-title":"Neuro-Oncology"},{"key":"84021_CR32","doi-asserted-by":"publisher","first-page":"101737","DOI":"10.1016\/j.redox.2020.101737","volume":"37","author":"MJ L\u00f3pez-Grueso","year":"2020","unstructured":"L\u00f3pez-Grueso, M. J. et al. Knockout of PRDX6 induces mitochondrial dysfunction and cell cycle arrest at G2\/M in HepG2 hepatocarcinoma cells. Redox Biol. 37, 101737. https:\/\/doi.org\/10.1016\/j.redox.2020.101737 (2020).","journal-title":"Redox Biol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-84021-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-84021-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-84021-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,3]],"date-time":"2025-01-03T17:03:47Z","timestamp":1735923827000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-84021-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,2]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["84021"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-84021-y","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4088599\/v1","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,2]]},"assertion":[{"value":"13 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"70"}}